US experience with watch and wait management approach from 33 centers--how do outcomes compare with previous reports? Find out in #DCRJournal: https://t.co/HcX6TI74k5
@SamuelHLai@JonVogel7@CUDeptSurg
Congratulations to Dr. Sam Lai, and the U.S. Rectal Cancer Research Group for their report on 545 patients managed with a watch and wait approach. Our group is recruiting more U.S. centers to collaborate. Join us! [email protected]
📚 Exciting new faculty and staff collaborative study! Noncomparable metrics are eliminated through holistic review process, leads to increase in URM applicants invited for residency interview! @cugites@CUDeptSurg@CUCancerCenter
https://t.co/LsiziixiTG
Laparoscopic TAP block with ropivicaine, decadron, and precedex significantly reduces opioid consumption following colorectal surgery #ASCRS22@SamuelHLai@CUDeptSurg@cugites
Adjuvant chemotherapy improves survival in patients with rectal cancer undergoing chemoradiation and TME even in presence of pCR. Excellent presentation by @SamuelHLai University of Colorado @CUDeptSurg@cugites@BrandonCChapman at #ASCRS22
Following suit with another BEST OF RECTAL CANCER plenary talk, Sam Lai (@SamuelHLai) presenting on the survival benefit of adjuvant chemotherapy after pCR following neoadjuvant long course chemorads in stage II/III rectal cancer #ASCRS22@CUDeptSurg@BrandonCChapman